Stay updated with breaking news from Nasdaq Rigl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Tuesday. Separately, HC Wainwright reissued a “buy” rating and issued a $15.00 price objective on shares of Rigel Pharmaceuticals in a research report on Wednesday, August 2nd. […]
StockNews.com upgraded shares of Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) from a hold rating to a buy rating in a report published on Thursday morning. Separately, HC Wainwright reaffirmed a buy rating and set a $15.00 target price on shares of Rigel Pharmaceuticals in a report on Wednesday, August 2nd. One analyst has rated the […]
StockNews.com upgraded shares of Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) from a hold rating to a buy rating in a research report released on Thursday morning. Separately, HC Wainwright reaffirmed a buy rating and set a $15.00 price objective on shares of Rigel Pharmaceuticals in a report on Wednesday, August 2nd. One investment analyst has […]
Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Thursday. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $15.00 price target on shares of Rigel Pharmaceuticals in a report on Wednesday. One […]
Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a report issued on Wednesday, Benzinga reports. They presently have a $15.00 target price on the biotechnology company’s stock. Separately, StockNews.com began coverage on shares of Rigel Pharmaceuticals in a research note on Thursday, May 18th. […]